Lupin Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is TENOFOVIR DISOPROXIL FUMARATE, with a corresponding US DMF Number 25787.
Remarkably, this DMF maintains an Active status since its submission on March 27, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 21, 2013, and payment made on February 04, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II